Chuck, the issue I see with Biotech stocks including IVX is that...

Chuck, the issue I see with Biotech stocks including IVX is that they all tend to go up on the announcement and then drifted lower afterward. Biotech stocks are not like your mining or other sectors which have frequent news to keep everyone excited. Especially when you have investors who are short to medium term, they tend to run out of patient and move on to other opportunities.

IVX has many irons in the fire which is very different from other Biotech that focus on one thing, so I believe when the time comes, we will get continuous ongoing news on different fronts to keep the momentum alive at all times.

I hope the management is reading this and has a roadmap plan for news flow and for god sake spend some money on PR ! The last announcement on the Hudson results did not get one media press release at all which is very poor in my view !!!